Necrotizing leukoencephalopathy following CHOP chemotherapy

Leukemia Research

Volumn 32, Issue 10, 2008, Pages 1611-1614

  Blaes, Anne H ^a   Santa Cruz, Karen S ^a   Lee, Chung K K ^a   Hui, Susanta K ^a   Peterson, Bruce A ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Chemotherapy; Leukoencephalopathy; Non Hodgkin lymphoma

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; VINCRISTINE;

ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; COMBINATION CHEMOTHERAPY; HUMAN; LEUKOENCEPHALOPATHY; MALE; MULTIPLE CYCLE TREATMENT; NECROTIZING LEUCOENCEPHALOPATHY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN DISEASES; CEREBRAL CORTEX; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DOXORUBICIN; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; PREDNISONE; VINCRISTINE;

EID: 44749090768     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2008.02.014     Document Type: Article

References (29)

1. Filley C.M., and Kleinschmidet-DeMasters B.K. Toxic leukoencephalopathy. NEJM 345 (2001) 425-432
2. Sheline G.E., Wara W.M., and Smith V. Therapeutic irradiation and brain injury. Int J Radiat Oncol Biol Phys 6 (1980) 1215-1228
3. Vick N.A., and Paleologos N.A. External beam radiotherapy: hard facts and painful realities. J Neurooncol 24 (1995) 93-95
4. Rosenberg N.L., Kleinschmidt-DeMasters B.K., Davis K.A., et al. Toluene abuse causes diffuse central nervous system white matter changes. Ann Neurol 23 (1988) 611-614
5. Dinwiddie S.H. Abuse of inhalants: a review. Addiction 89 (1994) 925-939
6. Lebrun C., Chanalet S., Frenay M., et al. Leukoencephalopathy in multiple myeloma: two case reports. Ann Oncol 10 (1999) 1515-1517
7. Hughes R.L. Cyclosporine-related central nervous system toxicity in cardiac transplantation. NEJM 323 (1990) 420-421
8. Mueller A.R., Platz K.-P., Bechstein W.-O., et al. Neurotoxicity after orthotopic liver transplantation: a comparison between cyclosporine and FK506. Transplantation 58 (1994) 155-170
9. Rubin A.M., and Kang H. Cerebral blindness and encephalopathy with cyclosporin A toxicity. Neurology 37 (1987) 1072-1076
10. Cain M.S., Burton G.V., and Holcombe R.F. Fatal leukoencephalopathy in a patient with non-Hodgkins lymphoma treated with CHOP chemotherapy and high-dose steroids. Am J Med Sci 315 (1998) 202-207
11. DeVita V.T., Canellos G.P., Chabner B., et al. Advanced diffuse histiocytic lymphoma, a potentially curable disease. Lancet 1 7901 (1975) 248-250
12. Fisher R.I., DeVita V.T., Hubbard S.M., et al. Diffuse aggressive lymphomas: increased survival after alternating flexible sequences of proMACE and MOPP chemotherapy. Ann Intern Med 98 3 (1983) 304-309
13. Gordon L.I., Harrington D., Andersen J., et al. Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphoma. NEJM 327 19 (1992) 1342-1349
14. Messori A., Vaiani M., Trippoli S., et al. Survival in patients with intermediate or high grade non-Hodgkin's lymphoma: meta-analysis of randomized studies comparing third generation regimens with CHOP. Br J Cancer 84 3 (2001) 303-307
15. Mackie T.R., Kapatoes J., Ruchala K., et al. Image guidance for precise conformal radiotherapy. Int J Radiat Oncol Biol Phys 56 1 (2003) 89-105
16. Li Y.X., Yao B., Jin J., et al. Radiotherapy as primary treatment for stage IE and IIE nasal natural killer/T-cell lymphoma. J Clin Oncol 24 1 (2006) 181-189
17. You J.Y., Chi K.H., Yang M.H., et al. Radiation therapy versus chemotherapy as initial treatment for localized nasal natural killer (NK)/T-cell lymphoma: a single institute survey in Taiwan. Ann Oncol 15 4 (2004) 618-625
18. Cheung M.M., Chan J.K., Lau W.H., et al. Early stage nasal NK/T-cell lymphoma: a clinical outcome, prognostic factors, and the effect of treatment modality. Int J Radiat Oncol Biol Phys 54 1 (2002) 182-190
19. Wang B., Lu J.J., Ma X., et al. Combined chemotherapy and external beam radiation for stage IE and IIE natural killer T-cell lymphoma of nasal cavity. Leuk Lymphoma 48 2 (2007) 396-402
20. Crossen J., Garwood D., Glatstein E., et al. Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy. J Clin Oncol 12 3 (1994) 627-642
21. Glusker P., Recht L., and Lane B. Reversible posterior leukoencephalopathy syndrome and bevacizumab. NEJM 354 9 (2006) 980-982
22. Kranick S.M., Mowry E.M., and Rosenfeld M.R. Progressive multifocal leukoencephalopathy after rituximab in a case of non-Hodgkin lymphoma. Neurology 69 7 (2007) 704-706
23. Steurer M., Clausen J., Gotwald T., et al. Progressive multifocal leukoencephalopathy after allogeneic stem cell transplantation and posttransplantation rituximab. Transplantation 76 2 (2003) 435-436
24. Lovblad K., Kelkar P., Ozdoba C., et al. Pure methotrexate encephalopathy presenting with seizures: CT and MRI features. Pediatr Radiol 28 (1998) 86-91
25. Edwards M.J., Walker R., Vinnicombe S., et al. Reversible posterior leukoencephalopathy syndrome following CHOP chemotherapy for diffuse large B-cell lymphoma. Ann Oncol 12 (2001) 1327-1329
26. Hurwitz R.L., Mahoney D.H., Armstrong A., et al. Reversible encephalopathy and seizures as a result of conventional vincristine administration. Med Pediatr Oncol 16 (1988) 216-219
27. Perry A., and Schmidt R.E. Cancer therapy-associated CNS neuropathology: an update and review of the literature. Acta Neuropathol (Berl) 111 3 (2006) 197-212
28. Sakamaki H., Onozawa Y., Yano Y., et al. Disseminated necrotizing leukoencephalopathy following irradiation and methotrexate therapy for central nervous system infiltration of leukaemia and lymphoma. Radiat Med 11 (1993) 146-153
29. Shapiro C., Hardenbergh P., Gelman R., et al. Cardiac effects of adjuvant doxorubicin and radiation therapy in breast cancer patients. J Clin Oncol 16 11 (1998) 3493-3501